Method Patent, Lilly Drug Patent Can Coexist, Fed. Circ. Rules
An earlier patent on a method of deriving the chemotherapy drug Alimta does not render Eli Lilly & Co.'s later patent on the drug itself invalid for double patenting, the Federal...To view the full article, register now.
Already a subscriber? Click here to view full article